ESRX - Express Scripts Holding Company

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
92.33
-3.47 (-3.62%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close95.80
Open95.57
Bid0.00 x 2900
Ask0.00 x 800
Day's Range92.11 - 95.80
52 Week Range66.93 - 101.73
Volume31,612,912
Avg. Volume6,857,277
Market Cap52.037B
Beta (3Y Monthly)N/A
PE Ratio (TTM)10.69
EPS (TTM)N/A
Earnings DateFeb 25, 2019 - Mar 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est92.56
Trade prices are not sourced from all markets
  • Richard Pzena Exits Express Scripts, Reduces Dover
    GuruFocus.com8 days ago

    Richard Pzena Exits Express Scripts, Reduces Dover

    Richard Pzena (Trades, Portfolio), t he founder and co-chief investment officer of Pzena Investment Management, sold shares of the following stocks during the fourth quarter. Warning! GuruFocus has detected 2 Warning Sign with QSR. The guru closed his Express Scripts Holding Co. (ESRX) stake.

  • The Wall Street Journal18 days ago

    [$$] Cigna Says Proposed Drug-Rebate Curbs Will Have Minimal Impact on Earnings

    Cigna Corp. said a new federal proposal that would curb rebates from drugmakers would have minimal impact on its results and offered conservative earnings guidance for 2019, the first year it will include the operations of Express Scripts Holding Co. Cigna said that for 2019, it projects adjusted income of $6.2 billion to $6.4 billion, or $16 to $16.50 per share. Analysts wrote that this range was slightly lower than consensus projections, but it included about $200 million, or 40 cents a share, in lingering overhead costs tied to Anthem Inc.’s early exit from its pharmacy-benefit contract with Express Scripts.

  • Cigna Corp (CI) Q4 2018 Earnings Conference Call Transcript
    Motley Fool18 days ago

    Cigna Corp (CI) Q4 2018 Earnings Conference Call Transcript

    CI earnings call for the period ending December 31, 2018.

  • Reuters19 days ago

    Cigna CEO shrugs off concerns about proposed change to rebate rules

    The U.S. government's proposal to eliminate rebates that pharmacy benefit managers receive from drugmakers will not have a meaningful impact on growth, and does not affect the commercial market, Cigna Corp Chief Executive Officer David Cordani said on Friday. Investors are worried that Cigna, which closed its $52 billion acquisition of PBM Express Scripts in December, could be hurt by the Trump administration's proposal targeting after-market discounts that middlemen in the pharmaceutical supply chain have received for decades.

  • Anthem Stock Hits Buy Point Intraday On Strong Outlook, Earnings
    Investor's Business Daily21 days ago

    Anthem Stock Hits Buy Point Intraday On Strong Outlook, Earnings

    Anthem stock vaulted higher, touching a buy point intraday, after the company issued a far-better-than-expected profit forecast this year.

  • The Wall Street Journal21 days ago

    Anthem's PBM Plans Boost Earnings Expectations

    Corp.’s recent acquisition of Express Scripts Holding Co., Anthem’s previous pharmacy-benefit manager, which allowed Anthem to terminate their contract well before the end of 2019, when the break had been expected. Anthem said it will exit the Express Scripts contract on March 1 and begin a yearlong process of transition the next day, with members beginning to migrate in the second quarter. Analysts wrote that the adjusted earnings projection handily beat consensus estimates of around $17.61, with the projected results boosted by several factors including expected membership growth, including in the Medicare Advantage program.

  • Moody's2 months ago

    Express Scripts Holding Company -- Moody's confirms Express Scripts at Baa2; stable outlook

    This concludes a rating review initiated on March 9, 2018 following the announcement that Cigna Corporation ("Cigna") reached a definitive agreement to acquire Express Scripts in a transaction valued at approximately $67 billion. Moody's changed the direction of the rating review from uncertain to downgrade on September 6, 2018.

  • Benzinga2 months ago

    Analysts: Cigna Offers Earnings Growth Potential, But Faces Legal Risks Tied To Aborted Anthem Deal

    Cigna Holding Co (NYSE: CI) recently completed its acquisition of pharmacy benefit manager Express Scripts. Raymond James analyst John Ransom upgraded Cigna from Market Perform to Outperform with a $215 price target. Wells Fargo Securities analyst Peter Costa maintained a Market Perform rating for Cigna and lowered the price target from $221 to $200.

  • GuruFocus.com2 months ago

    5 Health Care Stocks Gurus Are Buying

    Gilead on the list

  • 5 Great Healthcare Stocks to Buy for 2019
    Zacks2 months ago

    5 Great Healthcare Stocks to Buy for 2019

    Rapid innovation, major advances and an ageing population have managed to sustain the popularity of healthcare stocks.

  • 'Good for the region': Express Scripts CEO on what's next after the $54 billion Cigna buyout
    American City Business Journals2 months ago

    'Good for the region': Express Scripts CEO on what's next after the $54 billion Cigna buyout

    Express Scripts CEO Tim Wentworth on Thursday sought to calm fears that the company's $54 billion acquisition by insurer Cigna would negatively impact St. Louis.

  • Moody's2 months ago

    Connecticut General Life Insurance Company -- Moody's downgrades Cigna's long-term ratings (senior unsecured debt to Baa2); outlook stable

    Moody's Investors Service has downgraded Cigna Corporation's long-term ratings, including its senior unsecured debt rating to Baa2 from Baa1, upon the closing of its acquisition of Express Scripts Holding Company (ESI, Baa2, Review Down). Total senior unsecured debt of approximately $41 billion includes $20 billion issued by subsidiary Halfmoon Parent, Inc. (now known as Cigna Corporation), legacy Cigna Corporation (now known as Cigna Holding Company) debt of approximately $5.3 billion and legacy ESI debt of approximately $12.8 billion.

  • The Wall Street Journal2 months ago

    [$$] Cigna and Express Scripts Seal $54 Billion Merger

    Cigna Corp. completed its $54 billion acquisition of Express Scripts Holding Co., setting up a battle among giant health companies to try to cut health-care costs by managing both medical and drug benefits. The Cigna deal, which won an antitrust nod from the Justice Department without requiring divestitures, brings together a health insurer with a strong focus on employers with a major pharmacy-benefit manager. In an interview, Cigna Chief Executive David Cordani said an initial focus of the combined company will be on ensuring continued smooth business-as-usual operations, but it will begin rolling out new initiatives next year that seek to take advantage of the tie-up between medical and pharmacy oversight, including efforts focused on specialty pharmaceuticals and mental health.

  • Reuters2 months ago

    Cigna closes $54 billion purchase of Express Scripts

    Cigna Corp (CI.N) on Thursday closed its $54-billion (42.65 billion pounds) deal to buy Express Scripts Holding Co, creating one of the biggest providers of pharmacy benefits and insurance plans in the United States, a combination it says will help it improve healthcare coordination and cut costs. Cigna's deal puts it in direct competition with two other healthcare companies set up the same way - Aetna with CVS Health Corp (CVS.N) and UnitedHealth Group Inc (UNH.N) with Optum. Cigna's deal has already passed antitrust scrutiny.

  • Express Scripts, Cigna finalize $54 billion merger
    American City Business Journals2 months ago

    Express Scripts, Cigna finalize $54 billion merger

    Cigna closed on its acquisition of north St. Louis County-based Express Scripts Thursday after receiving final regulatory approval for the $54 billion deal on Wednesday.

  • See what the IHS Markit Score report has to say about Express Scripts Holding Co.
    Markit2 months ago

    See what the IHS Markit Score report has to say about Express Scripts Holding Co.

    This could indicate that investors who seek to profit from falling equity prices are not currently targeting ESRX. Index (PMI) data, output in the Healthcare sector is rising. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way.

  • MarketWatch2 months ago

    Celanese stock rises on inclusion to S&P 500

    Celanese Corp. shares rose in the extended session Wednesday after S&P Dow Jones Indices said the specialty chemical company would be joining the S&P 500 index . Celanese shares rose 4.8% after hours, following a 0.7% decline to close the regular session at $84.77. S&P said Celanese will trade on the index before the market opens on Monday, replacing Express Scripts Holding Co. which is being acquired by Cigna Corp.

  • PR Newswire2 months ago

    Celanese Set to Join S&P 500

    NEW YORK , Dec. 19, 2018 /PRNewswire/ -- Celanese Corp. (NYSE: CE) will replace Express Scripts Holding Co. (NASD: ESRX) in the S&P 500 effective prior to the open of trading on Monday, December 24 . S&P ...

  • Final state approves $54 billion Express Scripts, Cigna merger
    American City Business Journals2 months ago

    Final state approves $54 billion Express Scripts, Cigna merger

    On Tuesday, regulators from New Jersey approved the deal, according to a Securities and Exchange (SEC) filing Wednesday. Both Cigna and Express Scripts said they expect to close the transaction Thursday now that all regulatory approvals have been received. Although the combined company will be headquartered in Bloomfield, Connecticut, the Express Scripts headquarters is expected to remain in St. Louis, with Tim Wentworth, president and CEO of the organization, leading the unit.

  • ACCESSWIRE2 months ago

    Today's Research Reports on Trending Tickers: Centene and Express Scripts Holding

    NEW YORK, NY / ACCESSWIRE / December 18, 2018 / U.S. equities extended losses on Monday as investors await details from the Federal Reserve's final policy meeting of 2018 on Wednesday. The Dow Jones Industrial ...

  • Zacks2 months ago

    Here's Why You Should Buy Express Scripts (ESRX) Stock Now

    Strong demand for Express Scripts' (ESRX) solutions like SafeGuardRx, 90-day supply for chronic medications, exclusive Accredo Specialty Pharmacy and advanced opioid solutions buoy optimism.

  • Argentiere Capital’s Returns, AUM and Holdings
    Insider Monkey2 months ago

    Argentiere Capital’s Returns, AUM and Holdings

    Deepak Gulati‘s Argentiere Capital is a Zug, Switzerland-based hedge fund launched back in June 2013, with an additional office in Chicago. The fund is focused on offering its services to pooled investment vehicles and manages separate client-focused equity portfolios. It’s run by a team of former members of JP Morgan’s Global Equities Proprietary Trading Group […]

  • Only one state stands in the way of $54B Cigna/Express Scripts deal
    American City Business Journals2 months ago

    Only one state stands in the way of $54B Cigna/Express Scripts deal

    Only one state stands in the way of approving the $54 billion merger between Cigna and Express Scripts after government authorities in California and New York signed off on the deal Thursday. Both California's Department of Managed Health Care and New York's Department of Financial Services approved the deal and listed a set of conditions the companies agreed to. Conditions to the transaction in California Conditions to the transaction in New York Per the California approval, Cigna and Express Scripts agree to not increase premiums as a result of acquisition costs, and keep premium rate increases to a minimum.

  • Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?
    Zacks2 months ago

    Is Express Scripts Holding (ESRX) Stock Outpacing Its Medical Peers This Year?

    Is (ESRX) Outperforming Other Medical Stocks This Year?